Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Haitian Quan
Pharmacologic Characterization of TQ 05310, a Potent Inhibitor of Isocitrate Dehydrogenase 2 ( IDH 2) R140Q and R172K Mutants
Cancer Science
Cancer Research
Medicine
Oncology
Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor
Cancer Science
Cancer Research
Medicine
Oncology
Related publications
Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase (IDH) Mutations in Gliomas
Clinical Cancer Research
Cancer Research
Oncology
2-Hydroxyglutarate (2-Hg); Isocitrate Dehydrogenase 1 (IDH1)
Science-Business eXchange
Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Thrombospondin-2: A Potent Endogenous Inhibitor of Tumor Growth and Angiogenesis
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Interstitial Deletion of the Long ARM of Chromosome 2: A Dose Study on Isocitrate Dehydrogenase 1
Japanese journal of human genetics
Interstitial Deletion of the Long Arm of Chromosome 2 With Normal Levels of Isocitrate Dehydrogenase.
Journal of Medical Genetics
Genetics
Discovery of N-(2-Aminophenyl)-4-(Bis(2-Chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
Frontiers in Pharmacology
Pharmacology
Characterization ofEscherichia coliNull Mutants for Glutaredoxin 2
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology